DENISE FUHRMANN: Open Payments
NPI 1720179419 · BIDDEFORD, ME. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$594 in 10 payments from 4 companies in 2025. Trend: 2023 $495 · 2024 $581 · 2025 $594
Food & beverage: $594
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 4 | $176 |
| Otsuka America Pharmaceutical, Inc. | 2 | $144 |
| Axsome Therapeutics, Inc. | 2 | $138 |
| Neurocrine BioSciences, Inc. | 2 | $136 |
Products named: REXULTI, Auvelity, INGREZZA, LYBALVI, ARISTADA.
Industry payments across ME — which companies pay providers there.
